Streetbeat News

Analyst Ratings

SEMR

Jefferies upgraded SEMrush Holdings (NYSE:SEMR) to Buy from its previous rating, with a new price target of $15.00, up from $9.00. SEMrush's shares have risen 6.24% in the last 24 hours to $11.91. The new price target suggests a potential 25.94% increase from the current share price. SEMrush provides an online visibility management SaaS platform, generating revenue primarily from the US, the UK, and other regions.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 5:00 pm

PJT

Analyst ratings for PJT Partners (NYSE:PJT) have shown a diverse range of opinions, with recent updates indicating a generally positive outlook. The average 12-month price target has been raised to $101.2, reflecting a 2.48% increase from the previous target. Analyst actions from firms like JMP Securities, UBS, Goldman Sachs, and Wolfe Research have varied, with price targets adjusted accordingly. PJT Partners, an advisory-focused investment bank, has shown solid revenue growth and strong financial performance metrics such as ROE and ROA, despite facing challenges in market capitalization and net margin.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 5:00 pm

LIN

Wells Fargo has reaffirmed its Overweight rating on Linde (NASDAQ:LIN) and increased its price target from $470.00 to $480.00. Linde's shares have risen 0.63% in the last 24 hours to $418.18. The new price target suggests a potential 14.78% upside. Linde, the world's largest industrial gas supplier, reported $33 billion in revenue and $5.4 billion in GAAP operating profit for 2022.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 5:00 pm

CHKP

RBC Capital analyst Matthew Hedberg maintains a Sector Perform rating on Check Point Software (CHKP) and raises the price target from $159 to $165.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:58 pm

CARR

RBC Capital analyst Deane Dray maintains an Outperform rating on Carrier Global (NYSE:CARR) but lowers the price target from $63 to $60.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:56 pm

ARWR

RBC Capital analyst Luca Issi has reiterated an Outperform rating on Arrowhead Pharma (NASDAQ:ARWR) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:55 pm

CRNC

Cerence Inc. shares are trading lower due to the company's Q1 financial results and Q2 revenue guidance falling below estimates. Additionally, Craig-Hallum downgraded Cerence from Buy to Hold and set a $22 price target.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:54 pm

ARMK

RBC Capital analyst Ashish Sabadra has reiterated a 'Sector Perform' rating on Aramark (NYSE:ARMK) and maintained a price target of $33.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:52 pm

AMGN

RBC Capital analyst Gregory Renza maintains an Outperform rating on Amgen (NASDAQ:AMGN) and raises the price target from $303 to $329.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:50 pm

AME

RBC Capital analyst Deane Dray maintains an Outperform rating on AMETEK (AME) but lowers the price target from $192 to $188.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 4:48 pm